Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

Besides potential surface activity and some beneficial physical properties, biosurfactants
express antibacterial activity. Bacterial cell membrane disrupting ability of rhamnolipid …

Invasive aspergillosis and mucormycosis are life-threatening infections in solid organ and
hematopoietic cell transplant recipients. Despite medical advancements in the care of these …

Invasive aspergillosis (IA) is an important cause of infectious morbidity and mortality in
immunocompromised paediatric patients. Despite improvements in diagnosis, prevention …

Recent estimates suggest that more than 3 million people have chronic or invasive fungal
infections, causing more than 600,000 deaths every year. Aspergillus fumigatus causes …

Antifungal treatment is often ineffectual, partly because of biofilm formation. In this study, by
using a combined forward and reverse genetic strategy, we identified that nucleus-localized …

Introduction Invasive pulmonary aspergillosis (IPA) is an important cause of morbidity and
mortality in a wide range of patients. Early recognition and diagnosis have become a major …

In vitro interaction of voriconazole with micafungin was evaluated against 33 clinical
Aspergillus fumigatus isolates, including azole-resistant (n= 31) and-susceptible (n= 2) …

Aspergillus produces both airborne and waterborne infections with deadly consequences
depending on the species involved and the immune status of patients. Patients may remain …

Invasive aspergillosis (IA) is an infectious disease caused by Aspergillus species, is usually
seen in patients with immune deficiency and has been associated with high mortality rate. IA …